Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Injectable platelet-rich fibrin, a platelet concentrate in a liquid formulation, has been developed to provide clinicians with ease of use alone or in combination with various biomaterials. The low-speed centrifugation method provides a significant advantage to the regeneration process with richer platelets, leukocytes, and growth factors. It also contributes to the wound-healing process by increasing vascularization. It is expected that the application of injectable platelet-rich fibrin into the gingival pocket following subgingival curettage in periodontitis patients will positively affect the results of non-surgical periodontal treatment. For this reason, in this study it was aimed to investigate the early effects of injectable PRF applied into the pocket for root surface biomodification following subgingival curettage in periodontal pockets of 6 mm and above, by evaluating both clinical parameters and inflammatory and healing markers in the gingival groove fluid
The study was planned as a randomized controlled split-mouth clinical trial. A split-mouth design was used to better assess how the same host responded to two different treatment modalities. Two quadrants with contralateral deep periodontal pockets in each participant were selected and randomly divided into test and control groups.
Test group: Injectable platelet-rich fibrin application into the selected deep periodontal pocket after scaling and root planning (SRP) procedure.
Control group: No agent was applied to the periodontal pocket after scaling and root planning.
On the first visit, clinical periodontal measurements were taken before the SRP procedure. Plague index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL), and bleeding on probing (BOP) were used as clinical periodontal parameters.
After 1 week, the patients were called again for the SRP procedure. Injectable PRF obtained from the intravenous blood sample taken from the antecubital vein of the patients was injected into the deepened periodontal pocket subgingivally after the SRP procedure in the test group. Clinical periodontal measurements at 1 month and 3 months after SRP were repeated.
Gingival crevicular fluid (GCF) samples were taken from selected teeth before the SRP procedure. On the 3rd and 7th day after the SRP, GCF samples were taken again from the same region.
GCF vascular endothelial growth factor (VEGF), tumor necrosis factor-alpha (TNF-α), and interleukin (IL)-10 levels were evaluated by using the ELISA method and compared between groups.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SRP+i-PRF (test) | Injectable platelet-rich fibrin (i-PRF) application into the selected deep periodontal pocket after scaling and root planning (SRP) procedure. |
| |
| SRP (Control) | No agent was applied to the periodontal pocket after scaling and root planning. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| non surgical periodontal treatment | Procedure | scaling and root planning were applied for non-surgical periodontal treatment i-PRF application: Intravenous blood sample taken from the antecubital vein of the patients was collected in a 10 ml tube and centrifuged at 700 rpm for 3 minutes in a PRF centrifuge device. The PRF obtained from the upper liquid layer formed in the tube was injected subgingival into the deepest point of the pocket after SRP treatment. Clinical periodontal measurements: plaque index, gingival index, probing depth, clinical attachment level, bleeding on probing, and gingival recession were calculated. gingival crevicular fluid: Perio papers were placed in the deepest part of the sulcus and left for 30 seconds. After 30 seconds, the paper strips were placed in the periotron device and the volume was calculated. |
| Measure | Description | Time Frame |
|---|---|---|
| GCF VEGF levels in test and control groups | measure and compare the improvement of VEGF in test and control groups by using ELISA | Change from Baseline GCF VEGF levels at 3rd and 7th days |
| GCF TNF-alpha levels in test and control groups | measure and compare the improvement of TNF-alpha in test and control groups by using ELISA | Change from Baseline GCF TNF-alpha levels at 3rd and 7th days |
| GCF IL-10 levels in test and control groups | measure and compare the improvement of IL-10 in test and control groups by using ELISA | Change from Baseline GCF IL-10 levels at 3rd and 7th days |
| Plaque index (PI) | measure and compare the improvement of PI in test and control groups using a scale | Change from Baseline PI at 3rd and 7th days |
| Probing depth (PD) | measure the gingival margin to pocket bottom as mm and compare the improvement of PD in test and control groups | Change from Baseline PD levels at 3rd and 7th days |
| Gingival index (GI) | measure and compare the improvement of GI in test and control groups using a scale | Change from Baseline GI at 3rd and 7th days |
| Bleeding on probing (BOP) | Whether there is bleeding when the periodontal pocket is probed and comparing the improvement in test and control groups |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients with systemically healthy and stage 3 grade B periodontitis aged 18-65
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gizem Torumtay Cin, PhD | pamukkale university faculty of dentistry | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Gizem Torumtay Cin | Denizli | Deni̇zli̇ | 20070 | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28154995 | Background | Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, Choukroun J. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig. 2017 Nov;21(8):2619-2627. doi: 10.1007/s00784-017-2063-9. Epub 2017 Feb 2. | |
| 16504852 | Result | Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e56-60. doi: 10.1016/j.tripleo.2005.07.011. |
Not provided
Not provided
It is planned to be given if requested with a valid reason.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Change from Baseline BOP at 3rd and 7th days |
| Clinical attachment level (CAL) | measure the distance from the cemento-enamel line to the bottom of the pocket and compare the improvement in test and control groups | Change from Baseline CAL at 3rd and 7th days |
| 38153510 | Derived | Torumtay Cin G, Lektemur Alpan A, Cevik O. Efficacy of injectable platelet-rich fibrin on clinical and biochemical parameters in non-surgical periodontal treatment: a split-mouth randomized controlled trial. Clin Oral Investig. 2023 Dec 28;28(1):46. doi: 10.1007/s00784-023-05447-8. |